These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 2484766)
1. Extracorporeal LDL elimination with immunabsorption or heparin precipitation: a comparison in 10 patients. Richter WO; Vierneisel K; Schwandt P Beitr Infusionsther; 1988; 23():127-31. PubMed ID: 2484766 [No Abstract] [Full Text] [Related]
2. Extracorporeal LDL elimination with immunoabsorption or heparin precipitation: a comparison in 10 patients. Richter WO; Vierneisel K; Schwandt P Beitr Infusionsther; 1988; 23():127-31. PubMed ID: 2461762 [No Abstract] [Full Text] [Related]
3. Extracorporeal plasma therapy: the HELP system for the treatment of hyper-beta-lipoproteinemia. Armstrong VW; Eisenhauer T; Noll D; Wieland H; Scheler F; Seidel D Prog Clin Biol Res; 1988; 255():327-35. PubMed ID: 3277203 [No Abstract] [Full Text] [Related]
4. [Acute effects of extracorporeal LDL cholesterol and fibrinogen elimination on blood rheology and microcirculation]. Kleophas W; Leschke M; Tschöpe D; Martin J; Schauseil S; Schottenfeld Y; Strauer BE; Gries FA Dtsch Med Wochenschr; 1990 Jan; 115(1):3-7. PubMed ID: 2295300 [TBL] [Abstract][Full Text] [Related]
5. Treatment of severe hypercholesterolemia by heparin-induced extracorporeal LDL precipitation (HELP). Schuff-Werner P; Armstrong VW; Eisenhauer T; Thiery J; Seidel D Beitr Infusionsther; 1988; 23():118-26. PubMed ID: 2484765 [No Abstract] [Full Text] [Related]
6. Treatment of type IIa and type V hyperlipoproteinemia and of a normal volunteer by continuous LDL-apheresis. Riesen WF; Sturzenegger E; Imhof C; Descoeudres C; Mordasini R; Oetliker OH Prog Clin Biol Res; 1988; 255():337-46. PubMed ID: 3422496 [No Abstract] [Full Text] [Related]
7. [The extracorporeal elimination of LDL cholesterol by apheresis. The indications and methods]. Olbricht CJ Dtsch Med Wochenschr; 1991 Apr; 116(16):625-30. PubMed ID: 2015780 [No Abstract] [Full Text] [Related]
9. [Extracorporeal elimination of LDL-cholesterol in the treatment of hypercholesterolemia: indications and methods]. Bláha V; Havel E; Zadák Z; Pidrman V; Bláha M; Kalinová M Vnitr Lek; 1995 Oct; 41(10):724-9. PubMed ID: 8578708 [TBL] [Abstract][Full Text] [Related]
10. [H.E.L.P. apheresis and oxidative stress]. Pulawski E; Mellwig KP; Horstkotte D Z Kardiol; 2003; 92(Suppl 3):III38-41. PubMed ID: 14663600 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of selective LDL-removal in the treatment of familial hypercholesterolemia: double membrane filtration and adsorption system. Yamamoto A; Yokoyama S; Satani M; Kikkawa T; Kishino B Prog Clin Biol Res; 1988; 255():357-66. PubMed ID: 3340645 [No Abstract] [Full Text] [Related]
12. [Heparin-induced extacorporeal low-density lipoprotein-lipoprotein alpha-fibrinogen precipitation in 36 cases]. Mo JK; Li YX; Lei D; Wu DH Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):278-9. PubMed ID: 12390791 [TBL] [Abstract][Full Text] [Related]
13. [Heparin-induced extracorporeal LDL precipitation (HELP) in therapy refractory hypercholesterolemia and coronary heart disease: effect on clinical and morphological regression of coronary sclerosis]. Schuff-Werner P Z Kardiol; 1997; 86 Suppl 1():57-64. PubMed ID: 9173722 [TBL] [Abstract][Full Text] [Related]
14. [Plasma exchange therapy in a patient with familial hypercholesteremia and generalized arteriosclerosis]. Schrecker O; Thies K; Schlierf G Internist (Berl); 1984 Sep; 25(9):574-6. PubMed ID: 6386739 [No Abstract] [Full Text] [Related]
16. Six years of treatment with the HELP system of a patient with familial hypercholesterolemia. Nascimento MM; Pasqual DD; dos Santos JE; Riella MC Braz J Med Biol Res; 2002 Jul; 35(7):775-82. PubMed ID: 12131916 [TBL] [Abstract][Full Text] [Related]
17. Thermofiltration in hypercholesterolemia: analysis of removal and posttreatment cholesterol recovery. Malchesky PS; Nomura H; Werynski A; Takeyama Y; Yamashita M; Nosè Y Prog Clin Biol Res; 1990; 337():201-4. PubMed ID: 2352977 [No Abstract] [Full Text] [Related]
18. Type II hyperlipoproteinemia, hyperapobetalipoproteinemia, and hyperalphalipoproteinemia following renal transplantation: prevalence and precipitating factors. Lowry RP; Soltys G; Mangel R; Kwiterovitch P; Sniderman AD Transplant Proc; 1987 Feb; 19(1 Pt 3):2229-32. PubMed ID: 3547921 [No Abstract] [Full Text] [Related]